TY  - JOUR
AU  - Perez de Isla, Leopoldo
AU  - Alonso, Rodrigo
AU  - Watts, Gerald F.
AU  - Mata, Nelva
AU  - Saltijeral Cerezo, Adriana
AU  - Muniz, Ovidio
AU  - Fuentes, Francisco
AU  - Luis Diaz-Diaz, Jose
AU  - de Andres, Raimundo
AU  - Zambon, Daniel
AU  - Rubio-Marin, Patricia
AU  - Barba-Romero, Miguel A.
AU  - Saenz, Pedro
AU  - Sanchez Munoz-Torrero, Juan F.
AU  - Martinez-Faedo, Ceferino
AU  - Miramontes-Gonzalez, Jose P.
AU  - Badimon, Lina
AU  - Mata, Pedro
AU  - SAFEHEART Investigators
PY  - 2016
DO  - 10.1016/j.jacc.2016.01.008
SN  - 0735-1097
UR  - http://hdl.handle.net/10668/18806
T2  - Journal of the american college of cardiology
AB  - BACKGROUND Familial hypercholesterolemia (FH) is the most common genetic disorder associated with premature atherosclerotic cardiovascular disease (ASCVD). There are sparse data on attainment of treatment targets; large registries that reflect...
LA  - en
PB  - Elsevier science inc
KW  - cardiovascular disease
KW  - LDL-receptor mutations
KW  - lipid-lowering therapy
KW  - low-density lipoprotein cholesterol
KW  - Guidance
KW  - Management
KW  - Ezetimibe
KW  - Mortality
KW  - Efficacy
KW  - Therapy
KW  - Disease
KW  - Cohort
KW  - Risk
KW  - Care
TI  - Attainment of LDL-Cholesterol Treatment Goals in Patients With Familial Hypercholesterolemia 5-Year SAFEHEART Registry Follow-Up
TY  - research article
VL  - 67
ER  -